帕特诺利德通过阻断Smad2/3化通过Smad为受体激活来缓解腹膜纤维化
Ying Zhang1, Zebin Wang1, Liu Li2
1Department of Nephrology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
概括
帕瑟诺利德 (PTL) 通过准Smad对受体激活 (SARA) 来缓解腹纤维化. PTL 破坏了 SARA-Smad3 相互作用,改善了半体-半体过渡,并在腹腔透析并发症中恢复了 SARA 表达.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 渐进性腹膜纤维化是腹膜透析 (PD) 的严重并发症.
- 转化生长因子 (TGF) -β/Smad通路与纤维化有关.
- 在PD相关纤维化中,Smad对受体激活 (SARA) 的作用尚不清楚.
研究的目的:
- 为了阐明SARA在PD相关的腹膜纤维化中的作用.
- 为了研究帕氏化物 (PTL) 和SARA之间的关系.
- 确定PTL缓解腹纤维化的机制.
主要方法:
- 单细胞测序 (scRNA-seq) 数据分析.
- 收集和分析长期停留PD液体样本.
- 建立了PD小鼠模型,TGF-β1诱导的半体-半体过渡 (MMT) 模型,以及CRISPR/Cas9工程SARA基因 (ZFYVE9) 淘汰细胞系.
- 在体外和体外共免疫沉实验,分子对接和PTL-生物素拉下测试.
主要成果:
- SARA激活Smad2/3,Smad3促进SARA降解,导致纤维化进展期间SARA表达减少.
- 在不影响SARA蛋白稳定性的情况下,PTL抑制了SARA-Smad3相互作用.
- 在Smad3结合接口 (Pro788和Ser795残留物) 上,PTL直接与SARA结合.
结论:
- 通过酸化Smad2/3.3,SARA促进与PD相关的腹纤维化.
- 通过与SARA (ZFYVE9) 特别结合并破坏SARA-Smad3相互作用,PTL可以缓解腹膜纤维化.
- 这种机制恢复了SARA的表达,改善了MMT,并为腹膜纤维化临床治疗提供了理论基础.
相关概念视频
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
The JAK-STAT Signaling Pathway
12.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.1K


